PEOPLE - CardioGenesis makes appointment:
This article was originally published in Clinica
Executive Summary
Joseph Kletzel II has been appointed senior vice-president and general manager of CardioGenesis' pacific division, effective immediately. He has been a member of the board of directors for three years and will continue to serve on the board. He joins the cardiovascular disease device company, based in Foothill Ranch, California, from human tissue engineering firm Advanced Tissue Sciences.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.